Advanced Biomedical Research

Assessment of pyridoxine and folate intake in migraine patients

Authors

1 Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

2 Neurology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Migraine is a highly prevalent disorder worldwide. It affects 10–20% of the population during their lifetime. Recent studies have indicated that supplementation with folate and pyridoxine improves migraine symptoms. This study was undertaken to evaluate dietary intake of folate and pyridoxine in migraine patients and assessed their association with the frequency of migraine attacks.
Materials and Methods: This is a case–control study performed on 124 migraine patients and 130 non-migraine subjects. Individuals' common dietary intake was determined by using a valid semi-quantitative 168-item food frequency questionnaire (FFQ). Data had been analyzed using independent t-test using SPSS software (version 18).




Results: In this study, we found that migraine patients had lower intake of dietary folate compared with control group, but energy and pyridoxine intake were not different between the two groups. Further analysis among men and women revealed no statistically significant changes in these relationships. In addition, we found no significant association between dietary intake of pyridoxine and folate with the frequency of migraine attacks.
Conclusion: Migraine patients had lower dietary intake of folate, compared with non-migraine group subjects. There was no significant association between folate and pyridoxine intake with the frequency of migraine attacks. Further studies are needed to confirm our findings.

Keywords

1.
Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005;118:3-10S.  Back to cited text no. 1
    
2.
Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white abnormalities: A meta-analysis. Arch Neurol 2004;61:1366-8.  Back to cited text no. 2
    
3.
Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34.  Back to cited text no. 3
    
4.
Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, et al. European principles of management of common headache disorders in primary care. J Headache Pain 2007;8:3-47.  Back to cited text no. 4
    
5.
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-9.  Back to cited text no. 5
    
6.
Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol 2006;5:148-57.  Back to cited text no. 6
    
7.
Olesen J. The International Classification of Headache Disorders. 2nd ed. Ce phalalgi a, Valencia, Spain 2004;24:9-160.  Back to cited text no. 7
    
8.
Schurks M, Buring JE, Kurth T. Migraine, migraine features, and cardiovascular disease. Headache 2010;50:1031-40.  Back to cited text no. 8
    
9.
Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009;73:581-8.  Back to cited text no. 9
    
10.
Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005;330:63.  Back to cited text no. 10
    
11.
Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-4.  Back to cited text no. 11
    
12.
Panconesi A. Alcohol and migraine: Trigger factor, consumption, mechanisms. A review. J Headache Pain 2008;9:19-27.  Back to cited text no. 12
    
13.
Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001;41:554-8.  Back to cited text no. 13
    
14.
Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, et al. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 2012;13:595-606.  Back to cited text no. 14
    
15.
Camboim Rockett F, Castro K, Rossoni de Oliveira V, da Silveira Perla A, Fagundes Chaves ML, Schweigert Perry ID. Perceived migraine triggers: Do dietary factors play a role? Nutr Hosp 2012;27:483-9.  Back to cited text no. 15
    
16.
Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum 2012;18:796-806.  Back to cited text no. 16
    
17.
Lea R, Colson N, Quinlan S, Macmillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet Genomics 2009;19:422-8.  Back to cited text no. 17
    
18.
Hamatani R, Otsu M, Chikamoto H, Akioka Y, Hattori M. Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood. Clin Exp Nephrol 2013;4:12-7.  Back to cited text no. 18
    
19.
Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: A meta-analysis of prospective cohort studies. J Clin Epidemiol 2002;55:882-7.  Back to cited text no. 19
    
20.
Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics 2012;22:741-9.  Back to cited text no. 20
    
21.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Developmentand testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache related disability. Neurology 2001;56:S20-8.  Back to cited text no. 21
    
22.
Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain intake and the prevalence of hyperglyceridemic waiste phenotype in Tehranian adults. Am J Clin Nutr 2005;81:55-63.  Back to cited text no. 22
    
23.
Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran, Iran: Keshavarzi Press; 1999. p. 1-46.  Back to cited text no. 23
    
24.
Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, et al. The relationship between serum levels of vitamin D and migraine. J Res Med Sci 2013;18:S66-70.  Back to cited text no. 24
    
25.
Panconesi A. Alcohol and migraine: Trigger factor, consumption, mechanisms. A review. J Headache Pain 2008;9:19-27.  Back to cited text no. 25
    
26.
Molarius A, Tegelberg A, Ohrvik J. Socio-economic factors, lifestyle, and headache disorders - A population-based study in Sweden. Headache 2008;48:1426-37.  Back to cited text no. 26
    
27.
Moschiano F, D'Amico D, Usai S, Grazzi L, Di Stefano M, Ciusani E, et al. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci 2008;29:S173-5.  Back to cited text no. 27
    
28.
Di Rosa G, Attina S, Spano M, Ingegneri G, Sgro DL, Pustorino G, et al. Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms. Headache 2007;47:1342-4.  Back to cited text no. 28
    
29.
Jonasson T, Ohlin AK, Gottsater A, Hultberg B, Ohlin H. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease-a prospective randomized study of vitamin supplementation. Clin Chem Lab Med 2005;43:628-34.  Back to cited text no. 29
    
30.
Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002;288:2015-22.  Back to cited text no. 30
[PUBMED]    
Advanced Biomedical Research
Volume 2016, March
March 2016
Pages 1-5